Data gathered: November 17
AI Stock Analysis - Resmed (RMD)
Analysis generated May 1, 2024. Powered by Chat GPT.
Resmed is a global leader in the development, manufacturing, and marketing of medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. It primarily provides innovative products for sleep apnea treatment, including CPAP, Adaptive Servo-Ventilation, and other ventilatory devices. Also, Resmed has diversified into software solutions to streamline patient care and business workflows for healthcare professionals.
Stock Alerts - Resmed (RMD)
 |
Resmed | November 15 Insider Alert: De Witte Jan is selling shares |
|
Resmed | November 9 Insider Alert: FARRELL PETER C is selling shares |
|
Resmed | November 7 Job postings are up by 48% in the last couple of days. |
|
Resmed | November 3 Job postings are up by 125% in the last couple of days. |
Alternative Data for Resmed
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 339 | Sign up | Sign up | Sign up |
| Sentiment | 78 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,411,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 85 | Sign up | Sign up | Sign up |
| Patents | 840 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 197 | Sign up | Sign up | Sign up |
| Facebook Followers | 164,366 | Sign up | Sign up | Sign up |
| Instagram Followers | 5,187 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,651 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,551 | Sign up | Sign up | Sign up |
| Twitter Mentions | 15 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 46,200 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 46 | Sign up | Sign up | Sign up |
| Business Outlook | 73 | Sign up | Sign up | Sign up |
| Linkedin Employees | 7,742 | Sign up | Sign up | Sign up |
About Resmed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Price | $234.74 |
| Target Price | Sign up |
| Volume | 1,120,000 |
| Market Cap | $34.5B |
| Year Range | $172.67 - $255.53 |
| Dividend Yield | 0.92% |
| PE Ratio | 30.68 |
| Analyst Rating | 55% buy |
| Industry | Medical Devices |
In the news
 |
Venturi Wealth Management LLC Increases Stock Holdings in ResMed Inc. (NYSE:RMD)November 15 - ETF Daily News |
 |
Here's Why You Should Add RMD Stock to Your Portfolio NowNovember 14 - Yahoo |
|
Crossmark Global Holdings Inc. Has $1.89 Million Stock Position in ResMed Inc. (NYSE:RMD)November 13 - ETF Daily News |
|
Portside Wealth Group LLC Cuts Stock Position in ResMed Inc. (NYSE:RMD)November 10 - ETF Daily News |
|
Capital Performance Advisors LLP Takes $60,000 Position in ResMed Inc. (NYSE:RMD)November 10 - ETF Daily News |
|
QRG Capital Management Inc. Increases Holdings in ResMed Inc. (NYSE:RMD)November 8 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.25B | 759M | 717M | 311M | 395M | 2.200 |
| Q2 '24 | 1.19B | 763M | 716M | 292M | 389M | 2.080 |
| Q1 '24 | 1.21B | 742M | 693M | 300M | 382M | 2.130 |
| Q4 '23 | 1.17B | 811M | 647M | 209M | 283M | 1.880 |
| Q3 '23 | 1.11B | 734M | 600M | 219M | 298M | 1.640 |
Insider Transactions View All
| De Witte Jan filed to sell 6,723 shares at $248.8. November 14 '24 |
| FARRELL PETER C filed to sell 83,204 shares at $248.7. November 8 '24 |
| Rider Michael J filed to sell 10,443 shares at $242. November 5 '24 |
| Ghoshal Kaushik filed to sell 21,788 shares at $238.5. October 15 '24 |
| Sandercock Brett filed to sell 95,812 shares at $233.5. October 9 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$86.99 0% | 62 |
 |
Edwards LifesciencesEW |
$67.76 0% | 51 |
 |
Intuitive SurgicalISRG |
$527.61 0% | 71 |
 |
MedtronicMDT |
$87.53 0% | 57 |
 |
StrykerSYK |
$390.08 0% | 71 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Thomas Tuberville Republican |
Nov 16, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Resmed (RMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Resmed?
The Market Cap of Resmed is $34.5B.
What is Resmed's PE Ratio?
As of today, Resmed's PE (Price to Earnings) ratio is 30.68.
What is the current stock price of Resmed?
Currently, the price of one share of Resmed stock is $234.74.
How can I analyze the RMD stock price chart for investment decisions?
The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.
Does RMD offer dividends to its shareholders?
Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.92%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Resmed?
Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.